Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Sumitomo Pharma Co., Ltd.. A complete text table follows the diagram.
Japan is the next-largest disclosed stream in the latest EDINET half-year filing.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| North America | 1 | 163.0B | 71.8% of reported total |
| Japan | 1 | 46.9B | 20.6% of reported total |
| Asia | 1 | 17.3B | 7.6% of reported total |
| External customer revenue | 2 | 227.1B | Reported six-month total · ¥227.1B |
| Operating profit | 3 | 96.2B | 42.3% operating margin |
| Operating costs & expenses | 3 | 131.0B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 92.8B | Reported pretax result |
| Net non-operating cost | 4 | 3.4B | Arithmetic bridge to reported pretax profit |
| From | To | Value |
|---|---|---|
| North America | External customer revenue | 163.0B |
| Japan | External customer revenue | 46.9B |
| Asia | External customer revenue | 17.3B |
| External customer revenue | Operating profit | 96.2B |
| External customer revenue | Operating costs & expenses | 131.0B |
| Operating profit | Profit before tax | 92.8B |
| Operating profit | Net non-operating cost | 3.4B |